...
【24h】

Impaired proteasome function in Alzheimer's disease.

机译:阿尔茨海默氏病中蛋白酶体功能受损。

获取原文
获取原文并翻译 | 示例

摘要

Inhibition of proteasome activity is sufficient to induce neuron degeneration and death; however, altered proteasome activity in a neurodegenerative disorder has not been demonstrated. In the present study, we analyzed proteasome activity in short-postmortem-interval autopsied brains from 16 Alzheimer's disease (AD) and nine age- and sex-matched controls. A significant decrease in proteasome activity was observed in the hippocampus and parahippocampal gyrus (48%), superior and middle temporal gyri (38%), and inferior parietal lobule (28%) of AD patients compared with controls. In contrast, no significant decrease in proteasome activity was observed in either the occipital lobe or the cerebellum. The loss of proteasome activity was not associated with a decrease in proteasome expression, suggesting that the proteasome may become inhibited in AD by a posttranslational modification. Together, these data indicate a possible role for proteasome inhibition in the neurodegeneration associated with AD.
机译:抑制蛋白酶体的活性足以诱导神经元变性和死亡。然而,尚未证明神经变性疾病中蛋白酶体活性的改变。在本研究中,我们分析了来自16个阿尔茨海默氏病(AD)和9个年龄和性别匹配的对照的短时间死后尸检大脑中的蛋白酶体活性。与对照组相比,在AD患者的海马和海马旁回(48%),颞中上回(38%)和顶下小叶(28%)中发现了蛋白酶体活性的显着降低。相反,在枕叶或小脑中均未观察到蛋白酶体活性的显着降低。蛋白酶体活性的丧失与蛋白酶体表达的降低无关,表明蛋白酶体可能通过翻译后修饰而被AD抑制。总之,这些数据表明蛋白酶体抑制在与AD相关的神经变性中的可能作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号